Health
Could engineered red blood cells be an effective antiviral against SARS-CoV-2? – News-Medical.Net
In a new study, released on the bioRxiv* preprint server, a team of researchers explores the antiviral potential of red blood cells against severe acute respiratory…
Red blood cells are anucleate cells, which are the most abundant type of cell in the body, being present within all tissues, with a lifespan of 120 days. They also do not have class I major histocompatibility complex molecules, and thus, type O negative RBCs can be used by all patients. This automatically makes them ideal as delivery vehicles for therapeutic molecules, for a range of conditions, including the ongoing coronavirus disease 2019 (COVID-19) pandemic.
In a new study, released on the bioRxiv*…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News20 hours agoSunshine Coast women celebrated at 26th annual business awards